NYSE:PBH Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis → Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks (From The Oxford Club) (Ad) Free PBH Stock Alerts $64.43 -0.41 (-0.63%) (As of 02:27 PM ET) Add Compare Share Share Today's Range$63.79▼$64.6850-Day Range$62.62▼$71.7552-Week Range$56.25▼$75.31Volume87,423 shsAverage Volume244,096 shsMarket Capitalization$3.22 billionP/E Ratio15.45Dividend YieldN/APrice Target$91.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Prestige Consumer Healthcare alerts: Email Address Prestige Consumer Healthcare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside41.5% Upside$91.25 Price TargetShort InterestHealthy2.90% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment0.08Based on 10 Articles This WeekInsider TradingN/AProj. Earnings Growth7.01%From $4.42 to $4.73 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.47 out of 5 starsMedical Sector88th out of 917 stocksPharmaceutical Preparations Industry28th out of 431 stocks 3.3 Analyst's Opinion Consensus RatingPrestige Consumer Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoveragePrestige Consumer Healthcare has only been the subject of 2 research reports in the past 90 days.Read more about Prestige Consumer Healthcare's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.90% of the float of Prestige Consumer Healthcare has been sold short.Short Interest Ratio / Days to CoverPrestige Consumer Healthcare has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in Prestige Consumer Healthcare has recently decreased by 9.49%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldPrestige Consumer Healthcare does not currently pay a dividend.Dividend GrowthPrestige Consumer Healthcare does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePrestige Consumer Healthcare has received a 42.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Dental floss", "Topical capsaicin", "Mouthwash", "Lice shampoo", "Montelukast", and "Yeast infection medicine" products. See details.Environmental SustainabilityThe Environmental Impact score for Prestige Consumer Healthcare is -2.35. Previous Next 2.3 News and Social Media Coverage News SentimentPrestige Consumer Healthcare has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Prestige Consumer Healthcare this week, compared to 3 articles on an average week.Search Interest2 people have searched for PBH on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.60% of the stock of Prestige Consumer Healthcare is held by insiders.Percentage Held by Institutions99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Prestige Consumer Healthcare's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Prestige Consumer Healthcare are expected to grow by 7.01% in the coming year, from $4.42 to $4.73 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Prestige Consumer Healthcare is 15.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 137.63.Price to Earnings Ratio vs. SectorThe P/E ratio of Prestige Consumer Healthcare is 15.46, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 136.87.Price to Earnings Growth RatioPrestige Consumer Healthcare has a PEG Ratio of 1.87. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrestige Consumer Healthcare has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Prestige Consumer Healthcare's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Oxford ClubDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...Click here now to claim your FREE copy of Marc's AI playbook. About Prestige Consumer Healthcare Stock (NYSE:PBH)Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.Read More PBH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBH Stock News HeadlinesJune 13 at 6:16 AM | americanbankingnews.comAnalysts Offer Predictions for Prestige Consumer Healthcare Inc.'s Q1 2025 Earnings (NYSE:PBH)June 10, 2024 | americanbankingnews.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Rating of "Moderate Buy" from AnalystsJune 8, 2024 | americanbankingnews.comPrestige Consumer Healthcare Inc. Forecasted to Post FY2026 Earnings of $4.73 Per Share (NYSE:PBH)June 7, 2024 | americanbankingnews.comZacks Research Research Analysts Reduce Earnings Estimates for Prestige Consumer Healthcare Inc. (NYSE:PBH)June 6, 2024 | globenewswire.comPrestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce ConferenceMay 16, 2024 | markets.businessinsider.comPrestige Consumer Q4 Earnings Miss, Operating Margin FallsMay 16, 2024 | finance.yahoo.comPrestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights:May 16, 2024 | finance.yahoo.comPrestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: ...May 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Nyxoah (NYXH), Prestige Consumer Healthcare (PBH)May 14, 2024 | sfgate.comPrestige Consumer Healthcare: Fiscal Q4 Earnings SnapshotMay 14, 2024 | globenewswire.comPrestige Consumer Healthcare Inc. Reports Fiscal Year 2024 ResultsApril 25, 2024 | globenewswire.comPrestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings ResultsApril 3, 2024 | globenewswire.comDramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf BagMarch 23, 2024 | wsj.comPrestige Consumer Healthcare Inc.March 23, 2024 | finance.yahoo.comIs Prestige Consumer Healthcare Inc. (NYSE:PBH) Trading At A 49% Discount?March 15, 2024 | msn.comPerrigo has no exposure to infant formula litigation, CG saysMarch 8, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), Madrigal Pharmaceuticals (MDGL)February 18, 2024 | finance.yahoo.comPBH Mar 2024 55.000 putFebruary 18, 2024 | finance.yahoo.comPBH Jul 2024 70.000 callFebruary 16, 2024 | finance.yahoo.comInsider Sell: CFO Christine Sacco Sells 30,019 Shares of Prestige Consumer Healthcare Inc (PBH)February 11, 2024 | finance.yahoo.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?February 9, 2024 | msn.comPrestige Consumer Healthcare Begins Sharing Financial ResultsFebruary 9, 2024 | finance.yahoo.comPrestige Consumer Healthcare Third Quarter 2024 Earnings: EPS Beats ExpectationsFebruary 8, 2024 | seekingalpha.comPrestige Consumer Healthcare Inc. 2024 Q3 - Results - Earnings Call PresentationFebruary 8, 2024 | washingtonpost.comPrestige Consumer Healthcare: Fiscal Q3 Earnings SnapshotSee More Headlines Receive PBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/14/2024Next Earnings (Estimated)8/01/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPersonal Products Current SymbolNYSE:PBH CUSIP74112D10 CIK1295947 Webwww.prestigebrands.com Phone(914) 524-6800Fax302-674-5266Employees560Year FoundedN/APrice Target and Rating Average Stock Price Target$91.25 High Stock Price Target$117.00 Low Stock Price Target$65.00 Potential Upside/Downside+40.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$4.17 Trailing P/E Ratio15.55 Forward P/E Ratio14.67 P/E Growth1.87Net Income$209.34 million Net Margins18.60% Pretax Margin24.53% Return on Equity13.48% Return on Assets6.34% Debt Debt-to-Equity Ratio0.68 Current Ratio3.20 Quick Ratio2.02 Sales & Book Value Annual Sales$1.13 billion Price / Sales2.88 Cash Flow$4.88 per share Price / Cash Flow13.29 Book Value$33.34 per share Price / Book1.94Miscellaneous Outstanding Shares49,920,000Free Float49,116,000Market Cap$3.24 billion OptionableOptionable Beta0.50 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Ronald M. Lombardi (Age 60)Chairman, President & CEO Comp: $1.98MMs. Christine Sacco (Age 48)Chief Financial Officer Comp: $958.91kMr. Jeffrey Zerillo (Age 63)Senior Vice President of Operations Comp: $496.91kMr. William C. P'Pool (Age 59)Senior VP, General Counsel & Corporate Secretary Comp: $769.98kMr. Adel Mekhail (Age 63)Executive Vice President of Marketing & Sales Comp: $797.94kMr. Philip David TerpolilliDirector of Investor RelationsDean SiegalDirector of CommunicationsMs. Mary Beth FritzSenior Vice President of Quality & Regulatory AffairsMore ExecutivesKey CompetitorsInter ParfumsNASDAQ:IPARHerbalifeNYSE:HLFUSANA Health SciencesNYSE:USNANu Skin EnterprisesNYSE:NUSNature's Sunshine ProductsNASDAQ:NATRView All CompetitorsInsiders & InstitutionsEverSource Wealth Advisors LLCBought 208 shares on 6/11/2024Ownership: 0.001%Burney Co.Sold 4,559 shares on 5/22/2024Ownership: 0.031%Atria Investments IncBought 17,178 shares on 5/21/2024Ownership: 0.034%EMC Capital ManagementSold 1,031 shares on 5/20/2024Ownership: 0.014%Tidal Investments LLCBought 256 shares on 5/17/2024Ownership: 0.012%View All Insider TransactionsView All Institutional Transactions PBH Stock Analysis - Frequently Asked Questions Should I buy or sell Prestige Consumer Healthcare stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PBH shares. View PBH analyst ratings or view top-rated stocks. What is Prestige Consumer Healthcare's stock price target for 2024? 4 Wall Street research analysts have issued twelve-month target prices for Prestige Consumer Healthcare's stock. Their PBH share price targets range from $65.00 to $117.00. On average, they expect the company's share price to reach $91.25 in the next twelve months. This suggests a possible upside of 41.5% from the stock's current price. View analysts price targets for PBH or view top-rated stocks among Wall Street analysts. How have PBH shares performed in 2024? Prestige Consumer Healthcare's stock was trading at $61.22 at the start of the year. Since then, PBH stock has increased by 5.3% and is now trading at $64.47. View the best growth stocks for 2024 here. When is Prestige Consumer Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024. View our PBH earnings forecast. How were Prestige Consumer Healthcare's earnings last quarter? Prestige Consumer Healthcare Inc. (NYSE:PBH) released its quarterly earnings results on Tuesday, May, 14th. The company reported $1.02 EPS for the quarter, missing analysts' consensus estimates of $1.14 by $0.12. The firm earned $277 million during the quarter, compared to analysts' expectations of $287.42 million. Prestige Consumer Healthcare had a net margin of 18.60% and a trailing twelve-month return on equity of 13.48%. The firm's revenue for the quarter was down 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.07 earnings per share. What ETFs hold Prestige Consumer Healthcare's stock? ETFs with the largest weight of Prestige Consumer Healthcare (NYSE:PBH) stock in their portfolio include Invesco Pharmaceuticals ETF (PJP), Invesco S&P SmallCap Health Care ETF (PSCH), Congress SMid Growth ETF (CSMD), Schwab Ariel ESG ETF (SAEF), Global X Health & Wellness ETF (BFIT), iShares U.S. Pharmaceuticals ETF (IHE), SPDR S&P Pharmaceuticals ETF (XPH) and Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL). What guidance has Prestige Consumer Healthcare issued on next quarter's earnings? Prestige Consumer Healthcare issued an update on its FY25 earnings guidance on Tuesday, May, 14th. The company provided earnings per share (EPS) guidance of $4.40-$4.46 for the period, compared to the consensus estimate of $4.65. The company issued revenue guidance of $1.125-$1.140 billion, compared to the consensus revenue estimate of $1.16 billion. What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO? 8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Prestige Consumer Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA). Who are Prestige Consumer Healthcare's major shareholders? Prestige Consumer Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.57%), Ariel Investments LLC (5.16%), Allspring Global Investments Holdings LLC (2.11%), Allspring Global Investments Holdings LLC (2.11%), Westwood Holdings Group Inc. (1.82%) and Congress Asset Management Co. MA (1.54%). Insiders that own company stock include Mary Beth Fritz and Ronald M Lombardi. View institutional ownership trends. How do I buy shares of Prestige Consumer Healthcare? Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:PBH) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.